Adjuvant Quisinostat in High-Risk Uveal Melanoma — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Adjuvant Quisinostat in High-Risk Uveal Melanoma — Stella

Home/Uveal Melanoma/

View on ClinicalTrials.gov

Recruiting

Back to Uveal Melanoma trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

United States

University of Miami, Miami, Florida

Key details

Phase

Safety & dosing

Sponsor

University of Miami

Collaborators

Viriom, Joseph and Florence Mandel Family Foundation

Enrollment target

~63 participants

Started

May 2025

Primary completion

May 2030

Age range

19 Years and older

Last updated June 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.